Redmile Group is a healthcare investment organization that makes venture, growth, and crossover investing across healthcare.
Redmile Group is a healthcare investment organization that makes venture, growth, and crossover investing across healthcare.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 25, 2022
Rapt Therapeutics
|
Post-IPO Equity | $50M | Biotechnology | Yes |
Feb 16, 2022
Star Therapeutics
|
Series Unknown | $100M | — | |
Oct 7, 2021
Science 37
|
Post-IPO Equity | $200M | Biotechnology | — |
Sep 9, 2021
Mammoth Biosciences
|
Series D | $150M | Biotechnology | Yes |
Jul 13, 2021
Prime Medicine
|
Series B | $200M | Biotechnology | — |